President's Address

Liebeskind

David Liebeskind, MD, FAHA, FAAN, FSVIN, FWSO
UCLA Medical Center
Director, Neurovascular Imaging Research Core
Director, UCLA Comprehensive Stroke Center

More Info & Bio 

Dear colleagues,

During this global coronavirus pandemic, I welcome and appreciate the outpouring of effort and heartfelt emotion from so many healthcare providers in our community and beyond. Our society is focused on healthcare delivery and research progress in neurovascular disorders, seemingly far removed from an infectious pandemic, yet the overwhelming impact of this pandemic now extends to so many of us across the world. As the global pandemic evolves from one region to the next, we have witnessed incredible efforts and resourcefulness to limit the spread and impact of COVID-19. From the research labs and medical industry apparatus to the clinical front lines, there has been a groundswell of genuine devotion to a key facet of our mission in healthcare.

Our lives and daily routine rapidly changed to meet the needs of these unprecedented times, focusing our attention on how the Society of Vascular and Interventional Neurology (SVIN) can be most beneficial. Thanks to the pioneering work of my predecessors and close friends, for more than a decade SVIN has served a unique role. In academia, industry and the bedside, SVIN now celebrates numerous accomplishments that we have innovated and established together. Given the nature of the current environment, it is important that we focus attention on next steps in our field rather than laud prior accomplishments. My vision for the coming years in SVIN is to maximally enhance our impact in all spheres of neurovascular and interventional disorders, blurring any potential divisions across disciplines. Beyond SVIN, we seek to work closely in conjunction with other groups, specialists and societies in these endeavors. As part of new initiatives, enriching the diversity of our workforce across all backgrounds and career stages is a key priority.

Ongoing activities at SVIN have benefited from the determined energy of our members. The SVIN Registry continues to track and chronicle the profound impact we have realized in the treatment of acute ischemic stroke with endovascular therapy. In parallel, the SVIN COVID-19 Registry was launched in late March to study and learn from this global healthcare crisis. We continue to educate and rapidly communicate newfound lessons that affect our stroke and endovascular field. In late April, we will convene the SVIN Break 2020 to provide a virtual forum for ongoing education, addressing most pressing topics while looking to the coming months ahead. The MT2020 Committee continues their campaign to reduce the impact of stroke disability globally.  At the International Stroke Conference the committee announced the premier of a white paper, "Stroke Mechanical Thrombectomy: Building Systems of Care in your Region; Why and How? As a nimble society, we will adapt our SVIN Annual Meeting to these changing times, so please stay tuned.

Thank you for this opportunity to lead SVIN in these challenging times when we can collectively synergize our talents and expertise to achieve the greatest impact.

Sincerely,

David S Liebeskind, MD, FAAN, FAHA, FANA, FSVIN, FWSO

Director, Neurovascular Imaging Research Core
Director, UCLA Comprehensive Stroke Center

 

 

 

5841 Cedar Lake Road · Suite 204 | Minneapolis, MN 55416 | 952.646.2045 | info@svin.org
© 2019 Society of Vascular and Interventional Neurology. All Rights Reserved. Site by The Lone Designer
Privacy Policy | Terms of Service | Feedback
As a result of GDPR, our Privacy Notice and Terms of Service have been updated to better explain our relationship with you. Please click here to review our Privacy Policies. If you wish to opt in/out of receiving SVIN communication, please login to your SVIN account and update your Contact Info settings in your Member Profile.